Clozel J P, Tschopp T, Luedin E, Holvoet P
F. Hoffmann-La Roche & Co, Ltd, Pharmaceutical Research Department, Basel, Switzerland.
Circulation. 1989 Jan;79(1):125-33. doi: 10.1161/01.cir.79.1.125.
Tissue plasminogen activator is a thrombolytic agent that has been shown to be efficient in patients with myocardial infarction or pulmonary embolus. However, little is known about the time course and the dose dependency of its thrombolytic effect. The goal of our study was to investigate the time course of the thrombolysis induced by increasing doses of tissue plasminogen activator (t-PA) given either as a continuous infusion (0.0625-1 mg/kg) or as a bolus (0.05-0.4 mg/kg). For this purpose, we modified a previously described rabbit jugular vein thrombosis model by using an external gamma counter to follow continuously the thrombolysis. After administration of t-PA as either an infusion or a bolus, the rate and the extent of thrombolysis were dose dependent. The thrombus size decreased regularly following an exponential curve and reached a lower asymptote implicating an unlysable thrombus. As expected, after bolus injection, t-PA was rapidly inhibited resulting in a duration of action of approximately 15 minutes; this was independent of the dose. Surprisingly, during continuous infusion of t-PA for as long as 4 hours, the duration of action was limited to about 2 hours, although the plasma t-PA activity levels remained stable. Although the rate of inhibition was lower and thus the duration of action was longer during continuous infusion of t-PA than after a bolus injection, the extent of thrombolysis was similar when the same dose of t-PA was given as either a bolus or an infusion. These findings could be attributed to the higher initial rate of thrombolysis observed after a bolus injection.(ABSTRACT TRUNCATED AT 250 WORDS)
组织型纤溶酶原激活剂是一种溶栓剂,已证明对心肌梗死或肺栓塞患者有效。然而,关于其溶栓作用的时间进程和剂量依赖性知之甚少。我们研究的目的是调查通过持续输注(0.0625 - 1毫克/千克)或推注(0.05 - 0.4毫克/千克)给予递增剂量的组织型纤溶酶原激活剂(t - PA)所诱导的溶栓时间进程。为此,我们通过使用外部γ计数器持续跟踪溶栓过程,对先前描述的兔颈静脉血栓形成模型进行了改进。在给予t - PA输注或推注后,溶栓的速率和程度呈剂量依赖性。血栓大小按照指数曲线规律减小,并达到一个较低的渐近线,这意味着存在不可溶解的血栓。正如预期的那样,推注注射后,t - PA迅速被抑制,导致作用持续时间约为15分钟;这与剂量无关。令人惊讶的是,在持续输注t - PA长达4小时的过程中,作用持续时间限制在约2小时,尽管血浆t - PA活性水平保持稳定。虽然持续输注t - PA时抑制速率较低,因此作用持续时间较长,但与推注相同剂量的t - PA相比,溶栓程度相似。这些发现可能归因于推注注射后观察到的较高的初始溶栓速率。(摘要截短于250字)